Linked Life Data

19096466

Source:http://linkedlifedata.com/resource/pubmed/id/19096466

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
21
pubmed:dateCreated
2008-12-19
pubmed:abstractText
. In Norway, different attitudes prevail to discontinuation of antiplatelet agents, such as ASA, NSAID, ADP-receptor inhibitors (clopidogrel and ticlopidine) phosphodiestase inhibitors (dipyridamole) and glycoprotein IIb/IIIa receptor inhibitors (abciximab and eptifibatide), before endoscopic procedures. The Norwegian Association of Gastroenterology have appointed a group, consisting of a medical and a surgical gastroenterologist, a haematologist, a cardiologist and a pharmacologist, to review literature concerning the issue in order to give a recommendation.
pubmed:language
nor
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0807-7096
pubmed:author
pubmed:issnType
Electronic
pubmed:day
6
pubmed:volume
128
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2440-2
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
[Should platelet inhibitors be discontinued before gastrointestinal endoscopy?].
pubmed:affiliation
Gastromedisinsk avdeling Ullevål universitetssykehus 0407 Oslo. bjho@uus.no
pubmed:publicationType
Journal Article, English Abstract, Review